Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2025-05-02 Regulatory Filings
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획승인신청등결정) (안드로겐성 탈모가 있는 건강한 남성을 대상으로 OLX72021의 안전성과 유효성을 평가하기 위한 다기관, 무작위 배정, 이중 눈가림, 위약 대조, 다중 상승 용량 제1b/2a상 임상시험 계획 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (OliX) regarding the approval of a clinical trial (Phase 1b/2a for OLX72021). It is a formal disclosure of a material management event ('투자판단 관련 주요경영사항') submitted to the Korea Exchange (KRX). Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a standard regulatory disclosure of a business event, it is classified as a Regulatory Filing (RNS).
2025-05-02 Korean
투자판단관련주요경영사항 (GalNAcasiRNA 기술을 이용한 Option 1종 관련 마일스톤 기술료 수령)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the receipt of a milestone payment related to a technology licensing agreement (GalNAc-asiRNA). Since this is a specific corporate announcement regarding a financial event (milestone payment) that does not fit into categories like dividends, share issues, or board changes, it is classified as a general regulatory filing.
2025-04-30 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' category as it is a standard disclosure of an IR event schedule.
2025-04-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the National Pension Service's change in shareholding percentage in the company 'Olix'. This falls under the category of Major Shareholding Notification.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과), detailing the approval of financial statements, dividend decisions, and the election of directors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it confirms the outcomes of the shareholder votes.
2025-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of a new outside director (Kim Yang-kyun) for Olix Co., Ltd. This falls under the category of board and management changes.
2025-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.